Verisante Technology, Inc. provided an operational update. Verisante announced the Company has placed an Aura at the Restore Vein and Skin Centre in Kelowna, BC ('Restore'). Restore is a preeminent facility for skin health and cosmetic medicine servicing patients in Kelowna and the Okanagan Valley.

The Clinic's guiding principle of employing evidenced-based medicine and best-practice guidelines establishes the foundation for the very best patient care. Aura has also been gaining acceptance in Germany, led by Drs. at the HighLine Clinic in Bremen, who will be hosting an informational event for General Practitioners in Germany aimed at educating front line medical professionals on achieving better patient outcomes through the integrating Aura into their practice.

In addition to the market penetration being made with Aura, the Company also continues to make progress with applications for Verisante's Core sys tem for the detection of internal cancers. Earlier in 2015, the Company announced a collaboration between Verisante, the BC Cancer Agency and Imperial College Healthcare NHS Trust to develop an application that would use Verisante's Core laser raman system in a study to determine if the system is able to assist in ascertaining the margins between tumour and normal brain tissue. The initial results have been very encouraging as the study continues to enroll new patients.

The study is being led by Dr. Babar Vaqas, a Neurosurgeon and the Principal Investigator.